What Does “Standardised Extract” Mean in Supplements? Extract Ratios, Markers and Composition Explained
Share
“Standardised to 5%.”
“10:1 extract.”
“High-strength botanical extract.”
“Standardised for selected compounds.”
These phrases can make a botanical ingredient sound precise and scientifically controlled.
Sometimes they communicate genuinely useful information.
But they do not all mean the same thing.
A botanical ingredient is more than the name of a plant followed by an impressive percentage or ratio.
To understand what an extract actually is, several questions may matter.
Which botanical species was used?
Which part of the plant?
Is the ingredient a powder or an extract?
How was the preparation produced?
What does the extract ratio actually represent?
What constituent or marker is being measured?
And does the research being cited concern a sufficiently comparable preparation?
A useful starting principle is:
A standardised extract is not simply a stronger version of a plant. A standardisation statement describes control in relation to something defined — and you still need to know what that something is.
An important EU scope point: “standardised extract” is not one universal supplement category
Before interpreting the term, its legal context needs to be clear.
Plants and their preparations can be used in foods and food supplements, but their use is not governed by one specific fully harmonised EU legislative system. General food law still applies, including food-information and claims legislation, while relevant national rules can also apply.
This means we should not take a technical classification from another regulatory system and present it as though every EU botanical food supplement must follow that same classification.
In particular, EMA has detailed definitions for herbal substances and preparations in medicinal products.
Those definitions are extremely useful for understanding analytical concepts.
They are not automatically food-supplement definitions.
So throughout this article:
EMA terminology is used as a technical illustration, not as a claim that ordinary food supplements are regulated as herbal medicines.
“Standardised to 5%” sounds precise — but 5% of what?
A percentage creates an immediate impression of precision.
Consider:
standardised to 5% X
That tells you more than:
premium botanical extract.
But it still leaves important questions.
What is X?
Is it a defined constituent?
A group of constituents?
An analytical marker?
Something selected because it is relevant to biological activity?
Or simply the analyte chosen to control the preparation?
How was it measured?
And does the percentage refer to the genuine botanical extract, the complete commercial extract preparation or another defined basis?
A percentage becomes useful only when its subject is clear.
So:
“standardised” is not the end of the explanation. It creates the next question: standardised to what?
First: what is a botanical preparation?
A botanical ingredient can reach a supplement in very different forms.
It may be dried plant material that has been powdered.
Or the starting botanical material may undergo extraction, concentration, purification or other processing steps.
EMA's herbal medicinal-product framework defines herbal preparations broadly enough to include materials obtained through processes such as extraction, distillation, expression, fractionation, purification, concentration or fermentation.
That medicinal definition is not being imported as food law here.
It illustrates a basic compositional fact:
a plant powder and an extract are not automatically the same material.
EFSA's Compendium of Botanicals also highlights the importance of preparation. EFSA states that whether a substance occurring in a plant is present in a botanical preparation, and at what concentration, can depend substantially on the plant part, preparation method and conditions of use.
Therefore:
plant name alone is not a complete ingredient description.
For the broader formulation context, see How Is a Supplement Formula Built? Ingredients, Dosages and Purpose Explained.
Species and plant part matter
Even before extraction, botanical identity matters.
A common plant name may cover more than one species.
And different parts of the same species can have different compositions.
Root is not automatically equivalent to leaf.
Leaf is not automatically equivalent to fruit.
Fruit is not automatically equivalent to seed.
Within EMA's medicinal-herbal quality framework, detailed characterisation of extracts can include the scientific botanical name and plant part, alongside other preparation characteristics.
EFSA likewise warns that the relevance and concentration of particular botanical constituents can depend strongly on the plant part used.
The useful consumer principle is:
The same familiar plant name does not automatically mean the same ingredient.
Extraction changes the preparation
Extraction is not simply a way of making a plant smaller.
It changes how the botanical material is processed and can influence which components are present in the resulting preparation.
The final composition can depend on factors such as the starting material, plant part, extraction medium, processing conditions and subsequent concentration or processing.
That is why:
plant powder
and:
plant extract
should not automatically be treated as interchangeable.
And even two extracts made from the same species and plant part may not automatically be compositionally equivalent.
The preparation process becomes part of the ingredient description.
What does “standardised” actually mean?
This is where careful terminology matters most.
Within EMA's herbal medicinal-product framework, standardised herbal substances or preparations have a specific technical meaning: they are adjusted to a defined content of one or more constituents with known therapeutic activity. EMA separately categorises quantified preparations around active markers and other preparations around analytical markers.
Those distinctions belong to a medicinal-product quality system.
They are not universal legal classifications for botanical food supplements.
So when a food supplement itself uses language such as:
standardised to 5% X
we should not automatically assume that the product is using the word in EMA's formal medicinal sense.
The correct question is:
What does the manufacturer actually mean by “standardised”, and what evidence supports that meaning?
In practical terms, the statement should make clear what constituent, group of constituents or other compositional parameter is being controlled.
“Standardised”, “quantified” and “marker-controlled” should not be casually collapsed together
EMA's framework is particularly useful because it shows why these concepts should not automatically be treated as synonyms.
Within that framework:
a standardised herbal preparation relates to defined constituents with known therapeutic activity;
a quantified preparation relates to one or more active markers controlled within a specified range;
and an “other” preparation may use analytical markers for control without being adjusted to their content.
For a food-supplement article we should not label commercial botanical ingredients with these medicinal categories unless that classification is actually appropriate and documented.
But the underlying lesson is powerful:
Not every measured botanical constituent plays the same role.
A percentage can be analytically important without having the same scientific meaning as another percentage.
What is a marker?
A marker is a constituent or group of constituents selected for analytical purposes.
EMA's marker guidance explains that markers can support functions such as identification, quantification, analytical control and stability assessment.
Importantly, markers can serve these purposes irrespective of whether they themselves have therapeutic activity.
That gives us a key distinction:
A marker can be analytically useful without automatically being “the active ingredient”.
A marker can help answer questions such as:
Does this preparation contain what is expected?
How much of a selected component is present?
Does the measured value remain within defined limits?
But those functions do not automatically establish that the marker explains every biological property of the extract.
Analytical importance is not automatically biological importance
This distinction is easily lost in marketing.
A consumer may see:
5% X
and infer:
X is the reason the entire botanical “works”.
That conclusion may go beyond the evidence.
EMA's herbal medicinal-product system distinguishes between constituents with known therapeutic activity, active markers and analytical markers. An analytical marker can be selected for measurement even when its therapeutic relevance has not been established.
For food supplements, we should avoid casually borrowing the medicinal term active ingredient or implying therapeutic activity.
The broader scientific principle is enough:
A substance chosen for analytical control does not automatically represent the entire physiological meaning of a complex botanical preparation.
What does an extract ratio mean?
Botanical products sometimes display ratios such as:
5:1
10:1
or:
20:1.
These numbers can look intuitive.
But the precise meaning depends on how the ratio has been defined.
EMA's medicinal-herbal framework defines a Drug Extract Ratio (DER) as the relationship between the quantity of herbal substance used and the quantity of herbal preparation obtained.
It further distinguishes the genuine/native DER, based on genuine extract, from the total DER, which can relate to the whole extract including excipients.
That distinction is extremely important.
A commercial food supplement that simply prints:
10:1
should not automatically be assumed to be using exactly the EMA DERgenuine convention.
Therefore the safe consumer rule is:
An extract ratio is useful only when its calculation basis is clear.
A 10:1 extract is not automatically “10 times stronger”
This is one of the most important shortcuts to reject.
A 10:1 statement does not by itself establish:
ten times greater health effects;
ten times greater bioavailability;
ten times more of every plant constituent;
or:
ten times greater overall quality.
Extraction is selective.
The composition of the resulting preparation depends on what is extracted and retained under the chosen process.
A manufacturing ratio is therefore not an efficacy multiplier.
The precise conclusion is:
A defined extract ratio describes a relationship in manufacture. It does not, by itself, quantify biological effectiveness.
For the separate question of biological availability, see What Does Bioavailability Mean in Supplements?
Two “10:1” extracts may still be different ingredients
Even if two commercial ingredients both carry the same ratio, they may still differ in important respects.
They can use different species.
Different plant parts.
Different extraction solvents.
Different processing conditions.
Different genuine-versus-total ratio bases.
Different marker profiles.
Different standardisation criteria.
Different carriers or excipients.
And different finished compositions.
So:
same ratio does not automatically mean same extract.
Extraction solvent can matter
The extraction medium is another characteristic that can help define a preparation.
Within EMA's medicinal-herbal framework, extraction-solvent composition is part of the technical description of extracts.
The reason is straightforward.
A water extract and an extract produced using a hydroalcoholic system should not automatically be assumed to contain identical constituent profiles.
Consumers do not need to understand extraction chemistry.
The useful principle is:
How the extract is made can affect what the resulting preparation contains.
Genuine or native extract and commercial extract preparation can be different quantities
Another easy point of confusion is the weight of the extract itself.
Within EMA's medicinal framework, a genuine/native extract excludes excipients added after extraction. EMA distinguishes that from the whole extract preparation where other materials can be present.
This is another medicinal-product technical concept, not an automatic supplement-labelling rule.
But it explains why a commercial extract powder may contain:
the genuine botanical extract;
plus technological material used to produce a stable, usable powder.
Therefore:
commercial preparation weight is not automatically the same thing as genuine extract weight or marker amount.
This connects directly with What Does “99% Pure” Mean in Supplements? Purity, Assay and Ingredient Specifications Explained.
The common principle is:
Know what the number represents before comparing it.
Higher standardisation is not automatically better
Consider two extracts reporting different percentages of the same named constituent.
One reports:
5%
and another:
10%.
The second number is higher.
That is a compositional observation.
It is not yet a complete quality judgement.
You would still need to understand what is being measured, how the preparations differ, how much extract is consumed, whether the underlying analytical basis is comparable and what evidence exists for the respective preparations.
A higher constituent percentage does not automatically establish that a botanical extract is:
better;
safer;
more effective;
more appropriate for a particular product;
or better supported scientifically.
The useful rule is:
More concentrated is a compositional description before it is a superiority claim.
The same botanical name does not mean the same research material
This matters particularly when scientific studies are used in marketing.
Suppose a human study investigates one specific botanical extract.
That study may involve a defined species, plant part, preparation process, extraction solvent, compositional profile and dose.
Another commercial ingredient may share the same common plant name while differing significantly in those characteristics.
EMA's own medicinal-product comparability approach illustrates how botanical starting material, plant part, physical state, extraction solvent, DER and manufacturing process can all be relevant when comparing herbal active substances.
Again, we are not applying medicinal dossier requirements to supplements.
The scientific principle is:
A plant name alone is not enough to establish that two preparations are equivalent.
That links directly to What Does “Clinically Studied” Mean for a Supplement? Ingredient Evidence vs. Finished-Product Evidence.
The relevant question is not only:
Has this plant been studied?
It is also:
Is the ingredient being sold sufficiently comparable with the preparation that was actually studied?
Standardisation does not mean clinically studied
Standardisation and clinical research answer different questions.
A manufacturer can analytically control the composition of an extract without any clinical trial having been performed on that exact commercial material.
Conversely, clinical research may exist for a specific preparation, but another product cannot automatically inherit that evidence merely because the botanical name matches.
Therefore:
compositional control is not clinical validation.
And:
clinical evidence is not automatically transferable across botanically related but materially different preparations.
Standardisation does not automatically mean safer
Controlling composition can be useful.
But a standardisation percentage is not a universal safety certificate.
EFSA's Compendium of Botanicals is designed to support hazard identification. EFSA explicitly warns that the presence of a substance of concern in a plant does not automatically mean that it is present in a particular preparation at a concentration posing a risk, because plant part, preparation method and conditions of use matter.
EFSA also says inclusion in the Compendium does not itself mean a botanical is safe or unsafe.
Both shortcuts should therefore be avoided:
standardised = automatically safe
and:
natural = automatically safe or automatically unsafe.
Safety and compositional control are different questions.
Standardisation is not the same as purity
This connects directly with Article 7.
An extract may have a controlled level of one constituent or marker.
That does not automatically tell you:
the identity and amount of every other constituent;
whether every relevant contaminant has been tested;
whether the preparation has a particular universal purity percentage;
or whether every batch is chemically identical.
So:
A standardisation statement answers a defined compositional question. It does not replace broader characterisation or testing.
Does controlling one marker guarantee identical batches?
No.
Botanical extracts can be chemically complex.
Controlling a selected constituent can improve consistency for that specific parameter.
But EMA's marker guidance explicitly states that keeping selected markers within established limits does not by itself ensure complete batch-to-batch uniformity.
It also emphasises the importance of considering the broader herbal substance or preparation rather than only the selected marker.
That gives us another strong principle:
Controlling one marker does not make every constituent in a complex botanical preparation identical from batch to batch.
The evidence should therefore stay proportional to what the quality-control programme actually measures.
Extract ratio and standardisation answer different questions
These two numbers are sometimes displayed side by side, which can make them look like variations of the same measurement.
They are not.
A properly defined extract ratio describes a manufacturing relationship between botanical starting material and resulting preparation.
A standardisation statement describes control of a particular compositional characteristic.
An ingredient may provide information about both.
But one does not automatically establish the other.
A 10:1 extract is not necessarily standardised to a particular constituent.
And a botanical preparation with a controlled constituent percentage does not automatically have the highest or “best” extract ratio.
A percentage still needs a dose
Suppose a product accurately states:
5% of constituent X.
That percentage alone still does not tell you how much extract the recommended daily portion provides.
Five percent of a small amount and five percent of a larger amount are different quantities.
But that does not mean:
more is automatically better.
The correct interpretation requires both the percentage and the amount, together with the identity of the preparation and the evidence relevant to that use.
Therefore:
percentage without amount is incomplete.
And:
amount without preparation context is also incomplete.
Is “standardised to X%” automatically an authorised EU health claim?
No.
A statement describing the composition of an ingredient and a statement claiming a health benefit are not automatically the same thing.
Regulation (EC) No 1924/2006 defines a health claim as a claim that states, suggests or implies that a relationship exists between a food, food category or one of its constituents and health.
Therefore a factual statement such as:
standardised to X% of constituent Y
needs to be assessed according to what it actually communicates in context.
If surrounding marketing uses that percentage to state, suggest or imply a health relationship, health-claims law becomes relevant.
It would be equally inaccurate to say that every compositional standardisation statement is automatically a health claim.
Context matters.
Even a factual standardisation statement must not mislead
General EU food-information rules still apply.
Regulation (EU) No 1169/2011 prohibits misleading food information, including misleading information about identity, properties, composition, quantity and method of manufacture or production.
It also requires food information to be accurate, clear and easy to understand.
For voluntary food information, Article 36 additionally requires that it must not mislead, must not be ambiguous or confusing and, where appropriate, must be based on relevant scientific data.
So even when a botanical percentage is technically correct, the wider presentation should not turn it into an unsupported message such as:
more powerful;
clinically superior;
safer;
or:
more effective
unless those additional propositions have their own appropriate basis.
A practical eight-question botanical extract check
1. Which botanical species is used?
A common plant name may not be enough to establish the precise material.
2. Which plant part is used?
Root, leaf, fruit, seed and other plant parts should not automatically be treated as interchangeable.
3. Is the ingredient plant powder or an extract?
The preparation process can materially change the ingredient.
4. How is the extract defined?
Where relevant, look at preparation method, extraction medium and whether the ratio basis is clearly explained.
5. What does the extract ratio actually describe?
Do not automatically interpret a ratio such as 10:1 as an efficacy or strength multiplier.
6. What is being controlled or “standardised”?
Identify the named constituent, constituent group or analytical parameter behind the percentage.
7. What does that measured constituent represent?
Do not assume a measured marker automatically explains the full biological activity of the extract.
8. Does the evidence concern a sufficiently comparable preparation and dose?
Research on one extract should not automatically be transferred to another ingredient merely because both use the same plant name.
These questions are not intended to turn consumers into botanical chemists.
They prevent one percentage or ratio from replacing the identity of the ingredient.
How Primal Wolf approaches botanical standardisation
Primal Wolf's Brand DNA uses the principle:
Transparency over hype.
The brand direction is to explain what is in a formula, why it is there and what can actually be supported, while avoiding borrowed hype, vague superiority and claims that cannot be proven.
That becomes particularly important for botanicals.
Primal Wolf's own portfolio architecture places Shilajit and Ashwagandha in a separate VITALITY pillar and explicitly notes that claims in this area require particularly careful substantiation and EU compliance review.
Applied to botanical extracts, this means avoiding shortcuts such as:
10:1 means ten times stronger.
A higher marker percentage automatically means a better extract.
Standardised means clinically proven.
The same plant name means the same research evidence.
Instead, the preparation should be explained at the level the evidence supports.
The relevant questions are:
Which botanical is being used?
Which plant part?
What type of preparation?
How was the extract defined?
What does the ratio mean?
What constituent or marker is controlled?
What amount is supplied?
And is any research being referenced actually relevant to the material used?
That fits the broader internal Primal Wolf requirement that important quality and health statements should be capable of being evidenced.
Standardisation should make an ingredient more understandable, not merely more impressive
Botanical extracts can be complex materials.
That complexity is not itself a weakness.
But it means that one percentage cannot describe everything.
A compositional target can help control one aspect of a preparation.
A defined extract ratio can explain part of the manufacturing relationship.
A marker can support analytical control.
Botanical species and plant part can clarify identity.
Extraction details can help distinguish one preparation from another.
And clinical research can provide an additional evidence layer when the studied preparation is sufficiently comparable.
The mistake is collapsing all those layers into a single marketing shortcut.
A better evidence chain asks:
Which plant?
Which plant part?
Which preparation?
Which extraction system?
Which ratio and on what basis?
Which measured constituent or marker?
Which dose?
Which evidence?
Only then does a percentage become genuinely informative.
Know the plant. Know the preparation. Then judge the percentage.
Sources
- EFSA — Compendium of Botanicals
- EMA — Specifications and quality guidance for herbal substances and preparations
- EMA — Reflection paper on markers used for quantitative and qualitative analysis
- European Commission — Food Supplements
- Regulation (EC) No 1924/2006 — Nutrition and Health Claims
- Regulation (EU) No 1169/2011 — Food Information to Consumers
